133 related articles for article (PubMed ID: 9359727)
1. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
[TBL] [Abstract][Full Text] [Related]
3. Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5.
Hellman J; Loiselle PM; Zanzot EM; Allaire JE; Tehan MM; Boyle LA; Kurnick JT; Warren HS
J Infect Dis; 2000 Mar; 181(3):1034-43. PubMed ID: 10720528
[TBL] [Abstract][Full Text] [Related]
4. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
[TBL] [Abstract][Full Text] [Related]
5. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
Trautmann M; Hahn H
Infection; 1985; 13(3):140-5. PubMed ID: 3897069
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
7. Role of normal serum in the binding of lipopolysaccharide to IgG fractions from rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren HS; Glennon M; de Deckker FA; Tello D
J Infect Dis; 1991 Jun; 163(6):1256-66. PubMed ID: 1709961
[TBL] [Abstract][Full Text] [Related]
8. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.
Hellman J; Loiselle PM; Tehan MM; Allaire JE; Boyle LA; Kurnick JT; Andrews DM; Sik Kim K; Warren HS
Infect Immun; 2000 May; 68(5):2566-72. PubMed ID: 10768945
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
10. Outer membrane protein A (OmpA), peptidoglycan-associated lipoprotein (PAL), and murein lipoprotein (MLP) are released in experimental Gram-negative sepsis.
Hellman J; Warren HS
J Endotoxin Res; 2001; 7(1):69-72. PubMed ID: 11521086
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
[TBL] [Abstract][Full Text] [Related]
13. The porin protein of the outer membrane of Escherichia coli: reactivity in immunoblotting, antibody-binding by the native protein, and cross-reactivity with other enteric bacteria.
Henriksen AZ; Maeland JA
Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):315-21. PubMed ID: 2445170
[TBL] [Abstract][Full Text] [Related]
14. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
Tyler JW; Spears H; Nelson R
J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
[TBL] [Abstract][Full Text] [Related]
15. Protective capacity of antibodies to outer-membrane components of Escherichia coli in a systemic mouse peritonitis model.
Vuopio-Varkila J; Karvonen M; Saxén H
J Med Microbiol; 1988 Feb; 25(2):77-84. PubMed ID: 2448461
[TBL] [Abstract][Full Text] [Related]
16. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria.
Chaiyotwittayakun A; Burton JL; Weber PS; Kizilkaya K; Cardoso FF; Erskine RJ
J Dairy Sci; 2004 Oct; 87(10):3375-85. PubMed ID: 15377616
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to Escherichia coli J5 lipopolysaccharide and to Salmonella porin in patients with bacteremia.
Brauner A; Källenius G; Wrangsell G; Wretlind B; Svenson SB
Microb Pathog; 1986 Oct; 1(5):475-81. PubMed ID: 2854603
[TBL] [Abstract][Full Text] [Related]
18. Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.
Valentine CH; Hellman J; Beasley-Topliffe LK; Bagchi A; Warren HS
Mol Med; 2006; 12(9-10):252-8. PubMed ID: 17225874
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting.
de Jongh-Leuvenink J; Vreede RW; Marcelis JH; de Vos M; Verhoef J
Infect Immun; 1985 Dec; 50(3):716-20. PubMed ID: 3905612
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5.
Dunn DL; Ferguson RM
Surgery; 1982 Aug; 92(2):212-9. PubMed ID: 7048594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
